KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Amneal Pharmaceuticals (AMRX) Tax Rate (2017 - 2025)

Amneal Pharmaceuticals (AMRX) has 9 years of Tax Rate data on record, last reported at 10.25% in Q4 2025.

  • For Q4 2025, Tax Rate rose 4565.0% year-over-year to 10.25%; the TTM value through Dec 2025 reached 8.1%, up 4239.0%, while the annual FY2025 figure was 8.1%, 4239.0% up from the prior year.
  • Tax Rate reached 10.25% in Q4 2025 per AMRX's latest filing, down from 447.16% in the prior quarter.
  • Across five years, Tax Rate topped out at 447.16% in Q3 2025 and bottomed at 198.19% in Q3 2021.
  • Average Tax Rate over 5 years is 28.79%, with a median of 7.6% recorded in 2021.
  • Peak YoY movement for Tax Rate: surged 81333bps in 2021, then plummeted -22005bps in 2023.
  • A 5-year view of Tax Rate shows it stood at 25.12% in 2021, then surged by 196bps to 24.01% in 2022, then crashed by -149bps to 11.8% in 2023, then tumbled by -200bps to 35.4% in 2024, then soared by 129bps to 10.25% in 2025.
  • Per Business Quant database, its latest 3 readings for Tax Rate were 10.25% in Q4 2025, 447.16% in Q3 2025, and 31.14% in Q2 2025.